China approved its first homegrown mRNA vaccine for COVID-19, adding a key tool to combat future outbreaks of the virus that was missing due to Beijing’s reluctance to allow Western-made sho... Read more
Asia-focused insurer AIA Group’s net profit plummeted in 2022, as investment returns suffered amid rising interest rates, although the company sees positive trends this year in the key... Read more
China spent RMB 150 billion ($21.5 billion) in 2021 and 2022 to vaccinate the world’s largest population against COVID-19, according to the National Healthcare Security Administration (NHSA)... Read more
China’s top leaders said Thursday that the country has achieved “decisive victory” over COVID as its death toll drops sharply, reports Bloomberg. A meeting of the Politburo Standing Com... Read more
Chinese provinces spent at least RMB 352 billion ($51.6 billion) on COVID-19 containment in 2022, according to annual budget reports from local governments, adding strains to provi... Read more
You must be logged in to post a comment.